Annals of surgery · 2025
IBD-linked Genetic Variance in Intestinal Transplantation: A Multicenter Cohort Analysis.
СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dubois Antoine, Jans Deborah S, Canovai Emilio, Gentilini Maria V, Butler Andrew J, Amin Irum, Sharkey Lisa, Lacaille Florence, Chardot Christophe, Talayero Paloma, Lasa-Lazáro María, Calvo-Pulido Jorge, Wauters Lucas, Vanuytsel Tim, Gondolesi Gabriel E, Pirenne Jacques, Hannes Laurens, Fieuws Steffen, Cleynen Isabelle, Verstockt Sare, Ceulemans Laurens J
Аннотация
BACKGROUND: In solid organ transplantation, the intestine remains the most challenging. Previous studies have linked NOD2 genetic variation to intestinal transplantation (ITx) outcomes. Since then, a larger set of inflammatory bowel disease-associated genetic variants (IBDGVs) has been identified. This study aims to explore the prevalence and association of these IBDGVs with ITx outcomes.
METHOD: Clinical data and DNA from 150 donor/recipient pairs were collected from 5 ITx centers (Leuven, Cambridge, Paris, Madrid, Buenos Aires). Genotyping-by-sequencing of 540 IBDGVs was performed, and genetic European individuals (53 donors, 101 recipients, EUR cohort) were selected. Associations between ITx outcomes [patient/graft survival and acute/chronic rejection (AR/CR)] and IBDGVs were separately analyzed if carried by the donors, the recipients, and the donor-AND-recipient using Cox regression, followed by pathway analysis ( P <0.05).
RESULTS: Across all analyses (EUR cohort), multiple associations ( P <0.05) were identified between IBDGVs and ITx outcomes, including 79 with AR, 34 with CR, 113 with patient survival, and 102 with graft survival. Donor/recipient IBDGVs had mixed protective (HR<1) and detrimental influences (HR>1) on outcomes, while donor-AND-recipient IBDGVs were predominantly harmful. Pathway analysis of donor-AND-recipient IBDGV-related genes showed enrichment in innate/adaptive immunity and epithelial barrier function, particularly in IL-12 and S100 family signaling, phagosome formation, and microbial pattern recognition. Upstream regulatory analysis confirmed the link to microbial sensing (31% of the genes) and antibody-mediated immune responses (20%).
CONCLUSION: Several IBDGVs associated with ITx outcomes were identified in a multicenter genetic European cohort. These findings highlight potential markers for improving donor selection and post-transplant management.
METHOD: Clinical data and DNA from 150 donor/recipient pairs were collected from 5 ITx centers (Leuven, Cambridge, Paris, Madrid, Buenos Aires). Genotyping-by-sequencing of 540 IBDGVs was performed, and genetic European individuals (53 donors, 101 recipients, EUR cohort) were selected. Associations between ITx outcomes [patient/graft survival and acute/chronic rejection (AR/CR)] and IBDGVs were separately analyzed if carried by the donors, the recipients, and the donor-AND-recipient using Cox regression, followed by pathway analysis ( P <0.05).
RESULTS: Across all analyses (EUR cohort), multiple associations ( P <0.05) were identified between IBDGVs and ITx outcomes, including 79 with AR, 34 with CR, 113 with patient survival, and 102 with graft survival. Donor/recipient IBDGVs had mixed protective (HR<1) and detrimental influences (HR>1) on outcomes, while donor-AND-recipient IBDGVs were predominantly harmful. Pathway analysis of donor-AND-recipient IBDGV-related genes showed enrichment in innate/adaptive immunity and epithelial barrier function, particularly in IL-12 and S100 family signaling, phagosome formation, and microbial pattern recognition. Upstream regulatory analysis confirmed the link to microbial sensing (31% of the genes) and antibody-mediated immune responses (20%).
CONCLUSION: Several IBDGVs associated with ITx outcomes were identified in a multicenter genetic European cohort. These findings highlight potential markers for improving donor selection and post-transplant management.